Normal Ranges
Test*Name | Unit | N.Range*Male | N.Range*Female |
---|---|---|---|
HB | g/dl | 12 -16 | 11.5 – 15 |
FBG | mg/dL | N : 70 – 110 | N : 70 – 110 |
PPBG | mg/dL | N : 70 – 140 | N : 70 – 140 |
RBG | mg/dL | N : 80 – 120 | N : 80 – 120 |
ESR | mm/hr | 5 – 15 mm/hr | 5 – 20 mm/hr |
Urea | mg/dL | M : 15 – 45 | F : 15 – 45 |
Creatinine | mg/dL | M : 0.7 – 1.4 | F : 0.6 – 1.1 |
Uric Acid | mg/dL | M : 3.4 – 7 | F : 2.4 – 6 |
Cholesterol | mg/dL | N : up to 200 | N : up to 200 |
Triglycerides | mg/dL | M : Up to 150 | F : 3Up to 150 |
HDL-Cholesterol | mg/dL | N : > 35 | N : > 35 |
LDL-Cholesterol | mg/dL | N : up to 140 | N : up to 140 |
VLDL-Cholesterol | mg/dL | N : up to 30 | N : up to 30 |
SGPT | U/l | N : up to 40 | N : up to 40 |
SGOT | U/l | M : up to 37 | F : up to 31 |
GGT | U/l | M : 11 – 60 | F : 7 – 40 |
Alk.Phosphatase | U/l | Male : up to 115 | Female : up to 115 |
Bilirubin (Total) | mg/dL | 0-1 days: up to 8 1-2 days: up to 12 3-5 days: up to 16 >7 days: up to 10 Adult : up to 1.0 | 0-1 days: up to 8 1-2 days: up to 12 3-5 days: up to 16 >7 days: up to 10 Adult : up to 1.0 |
Bilirubin (Direct) | mg/dl | N : up to 0.25 | N : up to 0.25 |
Bilirubin (Indirect) | mg/dl | N : up to 0.75 | N : up to 0.75 |
Albumin | g/dl | N : 3.5 – 5.0 | N : 3.5 – 5.0 |
Globulin | gm/dl | N : 2 – 3.8 | N : 2 – 3.8 |
Total Protein | gm/dl | N : 6.6 – 8.7 | N : 6.6 – 8.7 |
Calcium (Total) | mg/dL | Child : 8 – 11 Adult : 8.1 – 10.4 | Child : 8 – 11 Adult : 8.1 – 10.4 |
Calcium (Ionized) | mg/dL | N : 4.6 – 5.2 | N : 4.6 – 5.2 |
Sodium | mEq/l | N: 135 – 155 | N: 135 – 155 |
Potassium | mEq/l | N : 3.6 – 5.5 | N : 3.6 – 5.5 |
Phosphorus | mg/dL | Child : 4 – 7 Adult : 2.5 – 5 | Child : 4 – 7 Adult : 2.5 – 5 |
Chloride | mEq/l | N : 98 – 107 | N : 98 – 107 |
HbA1c | % | Good Control : 4.5 – 7 Fair Control : 7.1 – 8.4 Uncontrolled : > 8.5 | Good Control : 4.5 – 7 Fair Control : 7.1 – 8.4 Uncontrolled : > 8.5 |
CPK | U/l | M : 25 – 195 | F : 24 – 170 |
CK-MB | ng/ml | N : up to 7.2 | N : up to 7.2 |
Troponin I | ng/ml | N : up to 1 | N : up to 1 |
Troponin T | pg/ml | N : up to 100 | N : up to 100 |
LDH | U/l | N : 230 – 460 | N : 230 – 460 |
FSH | mIU/ml | M : 1.6 – 11 | Follicular : 3.3 – 11 Luteal : 1.8 – 16 Midluteal : 5.2 – 20.4 Menopausal : 48.6 – 143.9 |
LH | mIU/ml | M : 0.8 – 9.1 | Follicular : 1.6 – 10.1 Luteal : 0.7 – 23.1 Midluteal : 13.2 – 82.7 Menopausal : 3.2 – 45.7 |
Progesterone | ng/ml | M : up to 1.7 | Follicular : up to 1.7 Luteal : 0.8 – 3 Midluteal : 1.7 – 27 Menopausal : up to 1.4 |
Prolactin | ng/ml | M : 2.7 – 16.9 | F : 3.9 – 29.5 |
Testosterone (Total) | ng/ml | M : 2.6 – 10.1 | F : 0.22 – 0.8 |
F.Testosterone | pg/ml | M : 50 – 300 | F : 1.5 – 6.5 |
Parathormone (PTH) | pg/ml | N : 10 – 71 | N : 10 – 71 |
ACTH (Am) | ng/ml | N : up to 120 | N : up to 120 |
Cortisol (Am) | µg/mL | N : 5 – 25 | N : 5 – 25 |
Cortisol (Pm) | µg/mL | N : 2.5 – 12.5 | N : 2.5 – 12.5 |
Growth Hormone | ng/ml | < 10 Years : up to 2 10 – 20 Years : Up to 5 > 20 Years : up to 1 | < 10 Years : up to 2 10 – 20 Years : Up to 15 > 20 Years : up to 10 |
DHEA | ng/dl | M : 150 – 1250 | F : 130 – 1000 |
DHEA-S | ng/dl | ||
17-OH Progestrone | ng/ml | M : 0.2 – 2.3 | Follicular : 0.2 – 1.3 Luteal: 1 – 4.5 Post menopausal: 0.2 – 0.9 |
AFP | ng/ml | M : up to 10 | up to 10 (for non pregnant female) |
CEA | ng/ml | N : up to 5 | N : up to 5 |
CA15.3 | U/ml | N : 6.4 – 58 | N : 6.4 – 58 |
CA125 | U/ml | N : up to 35 | N : up to 35 |
CA19.9 | U/ml | N : up to 37 | N : up to 37 |
PSA | ng/ml | N : 4 – 10 | N : 4 – 10 |
F.PSA | ng/ml | ||
Magnesium | mg/dL | N : 1.7 – 2.7 | N : 1.7 – 2.7 |
Multi-Drug Screen Panel | |||
Crabamazepine (Tegretol) | µg/mL | Therapeutic level: 4 – 12 | Therapeutic level: 4 – 12 |
Digoxin(Lanoxin) | ng/ml | Therapeutic level: 0.5 – 2 | Therapeutic level: 0.5 – 2 |
Phenytoin (Epanutin) | µg/mL | Therapeutic level: 10 – 20 | Therapeutic level: 10 – 20 |
Bleeding Time | min | N : up to 5 | N : up to 5 |
Coagulation Time | min | N : up to 10 | N : up to 10 |
PT | Sec | 8 – 16 | 8 – 16 |
PTT | Sec | N : up to 40 | N : up to 40 |
Iron | µg/mL | N : 0.4 – 1.3 | N : 0.4 – 1.3 |
Ferritin | ng/ml | M : 20 – 280 | F : 10 – 140 |
Transferrin | mg/dL | N : 200 – 360 | N : 200 – 360 |
TIBC | µg/mL | N : 1.6 – 5 | N : 1.6 – 5 |
HCT | % | 40 – 54 | 36 – 48 |
WBCs Count | x 10^3 | 4 – 11 | 4 – 11 |
PLTs Count | x 10^3 | 150 – 450 | 150 – 450 |
Reticulocytes | % | N : 0.5 – 2 | N : 0.5 – 2 |
G6PD | U/gmHb | N : 4.6 – 13.5 | N : 4.6 – 13.5 |
Fibrinogen | mg/dL | N : 180 – 350 | N : 180 – 350 |
D-Dimer | mg/L FEU | N : < 0.5 mg/L FEU | < 0.5 mg/L FEU |
Albumin/Creatinine Ratio | N : < 30 | N : < 30 | |
Total IgE | U/ml | N : up to 100 | N : up to 100 |
Herpes Simplex I IgM | AU/ml | N : up to 1.1 | N : up to 1.1 |
Herpes Simplex II IgM | AU/ml | N : up to 1.1 | N : up to 1.1 |
Herpes Simplex I IgG | AU/ml | N : up to 5.5 | N : up to 5.5 |
Herpes Simplex II IgG | AU/ml | N : up to 5.5 | N : up to 5.5 |
CMV IgM | IU/ml | N : up to 1.1 | N : up to 1.1 |
CMV IgG | IU/ml | N : up to 5.5 | N : up to 5.5 |
Rubella IgM | IU/ml | N : up to 1.1 | N : up to 1.1 |
Rubella IgG | IU/ml | N : up to 10 | N : up to 10 |
Toxoplasma IgM | IU/ml | N : up to 1.1 | N : up to 1.1 |
Toxoplasma IgG | IU/ml | N : up to 33 | N : up to 33 |
H.Pylori IgM | U/ml | N : up to 20 | N : up to 20 |
H.Pylori IgG | U/ml | N : up to 20 | N : up to 20 |
Schistosomiasis Ab Titre (IHA) | Diagnostic titre : 1/160 | Diagnostic titre : 1/160 |
|
ASOT | U/ml | N : < 200 | N : < 200 |
CRP | IU/ml | N : < 6 | N : < 6 |
RF | U/ml | N : < 8 | N : < 8 |
Rose Waaler | U/ml | N : < 6 | N : < 6 |
Anti-DNA (d.s) | U/ml | N : up to 30 | N : up to 30 |
ANA | U/ml | N : up to 1.5 | N : up to 1.5 |
Anti-Mitrochondial Ab (AMA) | N : < 1/20 | N : < 1/20 | |
ASMA | N : < 1/20 | N : < 1/20 | |
LKM Ab | N : < 1/20 | N : < 1/20 | |
Anti-Sperm Ab (IgM) | U/ml | N : up to 75 | N : up to 75 |
Anti-Sperm Ab (IgG) | U/ml | N : up to 75 | N : up to 75 |
Anti-Phospholipid IgM | U/ml | N : up to 10 | N : up to 10 |
Anti-Phospholipid IgG | U/ml | N : up to 10 | N : up to 10 |
PCR (HCV-RNA) | IU/ml | very low:<10.000 IU/mL low :10.000- 100.00 Intermediate:100.00 0-1.000.000 High :1.000.000-10.000.0 00 Very high: > 10.000.000 | very low:<10.000 IU/mL low :10.000- 100.00 Intermediate:100.0 00-1.000.000 High :1.000.000-10.000. 000 Very high: > 10.000.000 |
EBV-IgG | U/ml | N : up to 10 | N : up to 10 |
EBV-IgM | U/ml | N : up to 10 | N : up to 10 |
TB-Ab | Negative | Negative | |
Pregnancy (Urine) | Negative for the nonpregnant woman |
||
Pregnancy (Serum) | Negative for the nonpregnant woman |
||
Ceruloplasmin | mg/dL | N : 20 – 60 | N : 20 – 60 |
Osmotic Fragility | Negative | Negative | |
Anti-Cardiolipin IgM | U/ml | N : up to 7 | N : up to 7 |
Anti-Cardiolipin IgG | U/ml | N : up to 10 | N : up to 10 |
Amyloid A | mg/l | N : up to 6.8 | N : up to 6.8 |
Anti-Mullerian Hormone (AMH) | ng/ml | M : 0.2 – 2.3 | OPtimal fertility : 4 – 6.79 Satisfactory fertility : 1.26 – 3.9 Low fertility : 0.5 – 1.25 Very low fertility : up to 0.49 |
TPHA | Negative | Negative | |
BUN (Blood Urea Nitrogin) | mg/dL | N : 6 – 26 | N : 6 – 26 |
Ammonia | µg/dL | M : 25 – 94 | F : 19 – 82 |
Tramadole In Urine | Negative | Negative | |
Insulin Ab | U/ml | Up to 10 | Up to 10 |
T-Uptake | TBI | N : 0.8 – 1.3 | N : 0.8 – 1.3 |
C-Peptide | ng/mL | 0.5 to 2.7 | 0.5 to 2.7 |
Gastrin | pg/ml | N : 13 – 115 | N : 13 – 115 |
Anti-keratin Ab (AKA) | N : Less than 1/20 | N : Less than 1/20 | |
Anti-CCP | U/ml | N : less than 20 | N : less than 20 |
Calprotectin (Stool) | mg/kg | N : up to 50 | N : up to 50 |
Calprotectin (Plasma) | µg/mL | N : 0.3 – 1.6 | N : 0.3 – 1.6 |
Amylase | U/l | N : up to 95 | N : up to 95 |
T3 | ng/ml | N : 0.8 – 2 | N : 0.8 – 2 |
T4 | µg/mL | N : 4.7 – 13.5 | N : 4.7 – 13.5 |
TSH | µlU/mL | N : 0.27 – 4.2 | N : 0.27 – 4.2 |
F.T3 | pg/ml | N : 1.68 – 3.54 | N : 1.68 – 3.54 |
F.T4 | ng/dl | N : 0.9 – 1.9 | N : 0.9 – 1.9 |
Anti-Thyroglobulin-A B | IU/ml | N : up to 115 | N : up to 115 |
Anti-Peroxidase-Ab | IU/ml | N : up to 35 | N : up to 35 |
Microalbuminurea (Micral) | N : Less than 20 | N : Less than 20 | |
BHCG | µlU/mL | N: Up to 5.0 (for non pregnant) 1week :5-50 2week :40-1000 3week :100-5000 4seek :600-10000 5-6w :1500-100000 7-8w :16000-200000 2-3m :12000-300000 2nd trimester :24000-55000 |
|
Anti-SSA (RO) | IU/ml | N : up to 20 | N : up to 20 |
Anti-SSB (LA) | IU/ml | N : up to 20 | N : up to 20 |
Lactoferrin | ng/kg | Negative : up to 25 | Negative : up to 25 |
HOMA-IR | N : Less than 1 | N : Less than 1 | |
Typhi (H) (Widal) | N : < 1/80 | N : < 1/80 | |
Typhi (O) (Widal) | N : < 1/80 | N : < 1/80 | |
Paratyphi (A) (Widal) | N : < 1/80 | N : < 1/80 | |
Paratyphi (B) (Widal) | N : < 1/80 | N : < 1/80 | |
B.Abortus (Brucella) | N : < 1/80 | N : < 1/80 | |
B.Melitenesis (Brucella) | N : < 1/80 | N : < 1/80 | |
ESR (1st hr) | mm/hr | New born : 0 -2 Up to puberty : 3 – 13 15-50 Yrs : up to 15 > 50 Yrs : up to 20 | New born : 0 -2 Up to puberty : 3 – 13 15-50 Yrs : up to 20 > 50 Yrs : up to 30 |
17-Keto-Steroids | mg/day | M : 10 – 25 | F : 6 – 14 |
Total Lipids | mg/dL | N : 400 – 1000 | N : 400 – 1000 |
Cholesterol/HDL | 1/2 Average : 3.9 1/2 Average : 4.4 2 Average : 7.1 3 Average : 11 | 1/2 Average : 3.9 1/2 Average : 4.4 2 Average : 7.1 3 Average : 11 |
|
M2PK (EDTA) | U/ml | N : up to 15 | N : up to 15 |
Prothrombin Time | Sec | N : 11 – 14 Control Time : 12 | N : 11 – 14 Control Time : 12 |
Prothrombin Conc. | % | N : 70 – 110 | N : 70 – 110 |
INR | N : 0.9 – 1.3 For oral anticoaqulant therapy : 2 – 3.5 | N : 0.9 – 1.3 For oral anticoaqulant therapy : 2 – 3.5 |
|
GTT-FBG | mg/dL | N :70 – 110 | N :70 – 110 |
Fructoseamine | mmol/l | 2 – 2.8 Good Control : 4.5 – 7 Fair Control :3.3 – 3.8 Uncontrolled : > 3.8 | 2 – 2.8 Good Control : 4.5 – 7 Fair Control :3.3 – 3.8 Uncontrolled : > 3.8 |
5-Nucleotidase | U/l | N : 3 – 20 | mg/l |
Globulin | gm/dl | N : 2 – 3.8 | N : 2 – 3.8 |
Lipase | U/l | N : 13 – 60 | N : 13 – 60 |
Pancreatic Amylase | U/l | N : 13 – 53 | N : 13 – 53 |
Fructose in Semen | mg/dL | N : 200 – 400 | N : 200 – 400 |
ACTH (Pm) | pg/ml | N : up to 85 | N : up to 85 |
Anti-Sperm Ab (IgA) | U/ml | N : up to 75 | N : up to 75 |
Varicella (Chickenpox) IgG | U/ml | N : up to 10 | N : up to 10 |
Varicella (Chickenpox) IgM | U/ml | N : up to 10 | N : up to 10 |
Zinc | µg/dL | N : 46 – 150 | N : 46 – 150 |
Fecal Occult Blood (FOB) | Negative | Negative | |
Anti Microsomal Antibody | IU/mL | 0.0-9.0 | 0.0-9.0 |
Anti thrombin III | % | 80% -130% | 80% – 130% |
Anti Diuretic hormone | |||
Anti Centromere | |||
Anti-RNP | |||
Anti Scl 70 | |||
Anti Smooth muscle antibody | |||
Anti reticulin | |||
Anti Jo1 | |||
Anti Parietal Cell Antibody (APA) | |||
Anti-gliadin IgA | |||
Anti-gliadin IgG | |||
AST/ALT Ratio | |||
Ambeic antibody | |||
B2 Microglobulin (Serum) | |||
B2 Microglobulin (Urine) | |||
Biotin | |||
SO2 | |||
PaCO2 | |||
O2 Saturation | |||
HCO3 | |||
CD2 | |||
CD3 | |||
CD4 | |||
CD5 | |||
CD7 | |||
CD8 | |||
CD10 | |||
CD13 | |||
CD14 | |||
CD14 | |||
CD15 | |||
CD16 | |||
CD19 | |||
CD20 | |||
CD22 | |||
CD23 | |||
CD30 | |||
CD33 | |||
CD34 | |||
CD38 | |||
CD41a | |||
CD45 | |||
CD55 | |||
CD56 | |||
CD59 | |||
CD61 | |||
CD62p | |||
CD64 | |||
CD79a | |||
CD79b | |||
CD103 | |||
CD117 | |||
CD138 | |||
FMC-7 | |||
Glycophorin A | |||
HLA-DR | |||
IgM | |||
IgG | |||
Kappa | |||
Lambda | |||
MPO | |||
ZAP-70 | |||
TdT | |||
WBCs & Diffrential Count | |||
Hb Electrophoreses | |||
Hb (A) (Hb.E) | |||
Hb (A2) (Hb.E) | |||
Hb (F) (Hb.E) | |||
Hb (S) (Hb.E) | |||
Hb (C) (Hb.E) | |||
Creatinine Clearance | |||
Serum Creatinine (Creat.C) | |||
Urine Creatinine (Creat.C) | |||
Urine Volume (Creat.C) | |||
Creatinine Clearance (Creat.C) | |||
Breast Discharge Culture | |||
Eye Culture | |||
Ear Discharge Culture | |||
Pus From Wond Culture | |||
Nasal Swab Culture | |||
Throat Swab Culture | |||
Prostatic Secreation Culture | |||
Vaginal Swab Culture | |||
Conjuntival Swab Culture | |||
Gum Discharge Culture | |||
Synovial Fluid Culture | |||
Semen Culture | |||
Protein Electrophoresis | |||
Albumin (Pro.E) | |||
Alpha-2 Globulin (Pro.E) | |||
Beta Globulin (Pro.E) | |||
Gama Globulin (Pro.E) | |||
Total Protein (Pro.E) | |||
Weil Felix Test | |||
Proteus OX19 (Weil.F) | |||
Proteus OX2 (Weil.F) | |||
Proteus OXK (Weil.F) | |||
Prostatic Discharge Examination | |||
PCR for HBV | IU/ml | Very low : less than 10,000 Low : 10,000- 100,000 Intermediate : 100,000-1,000,000 High : 1,000,000-10,000,00 0 Very high: more than 10,000,000 | Very low : less than 10,000 Low : 10,000- 100,000 Intermediate : 100,000-1,000,000 High : 1,000,000-10,000,0 00 Very high: more than 10,000,000 |
Androstenedione | ng/ml | M : 0.91 – 3 | F : 0.57 – 2.63 |
DHT | ng/ml | M : 25 – 90 | F : 2 – 20 |
Estriol (E3) | ng/ml | 1st : trimester up to 0.48 2nd : trimester 0.2 – 4.43 3rd : trimester 1.47 -13.9 |
|
Inhibin A | pg/ml | ||
Inhibin B | pg/ml | M: 25 – 325 | Premenopausal : 15 – 200 Postmenopausal : < 15 |
5-HIAA | mg/day | 2 – 6 | 2 – 6 |
Acid Phosphatase | U/l | M : up to 6.6 | F : up to 6.5 |
AFP-L3 | ng/ml | Up to 4 | Up to 4 |
Ca 242 | U/ml | Less than 20 | Less than 20 |
Ca 72.4 | ng/ml | Up to 4 | Up to 4 |
Ca- 50 | IU/ml | Less than 25 | Less than 25 |
Calcitonin | pg/ml | M : up to 30 | F : up to 13 |
Chromogranin A | ng/ml | Up to 100 | Up to 100 |
CYFRA 21 | ng/ml | Up to 3.3 | Up to 3.3 |
NMP-22 | U/ml | Less than 7.5 | Less than 7.5 |
NSE (neuron specific enulase) | ng/ml | Up to 15.2 | Up to 15.2 |
Pro-GRP | pg/ml | Up to 100 | Up to 100 |
PIVKA II (protein-induced vitamin K antagonist II) | ng/ml | Up to 2 | Up to 2 |
Prostatic acid phosphatase (mass) | ng/ml | Up to 3.5 | Up to 3.5 |
SCC Ag(Squamous cell carcinoma Antigen) | µg/L | 0.16 – 1.5 | 0.16 – 1.5 |
Thyroglobulin | ng/ml | 1.4 – 78 | 1.4 – 78 |
Acetylcholine Receptor Ab | nmol/l | Negative : Less than 0.25 Equivocal : 0.25 – 0.4 Positive : more than 0.4 | Negative : Less than 0.25 Equivocal : 0.25 – 0.4 Positive : more than 0.4 |
AMA (Antimitochondrial Antibody) | Less than 1/20 | Less than 1/20 | |
Anti- DFS-70 | AU | up to 10 | up to 10 |
Anti-Myeloperoxidas e | U/ml | Up to 6 | Up to 6 |
Anti-Proteinase-3 | U/ml | Up to 2 | Up to 2 |
Anti-Asialoglycoprot ein receptor ( ASGPR)( IgG) | U/ml | Negative : less than 0.9 Equivocal : 0.9 – 1.1 Positive : more than 1.1 | Negative : less than 0.9 Equivocal : 0.9 – 1.1 Positive : more than 1.1 |
Anti-Intrinsic Factor (Ab) (IgG) | Negative index : less than 1 | Negative index : less than 1 |
|
Anti-Saccharomyces cerevisiae Ab (ASCA-IgA) | U/ml | Negative : Less than 20 | Negative : Less than 20 |
Anti-Saccharomyces cerevisiae Ab (ASCA-IgG) | U/ml | Negative : Less than 20 | Negative : Less than 20 |
Anti-Canalicular Ab | Less than 1/20 | Less than 1/20 | |
Anti-Desmoglein-1 IgG | RU/ml | Negative : Less than 20 | Negative : Less than 20 |
Anti-Desmoglein-3 IgG | RU/ml | Negative : Less than 20 | Negative : Less than 20 |
Anti- DGP | U/ml | Negative : up to 3 | Negative : up to 3 |
Anti-GBM | Less than 1/20 | Less than 1/20 | |
Anti-GAD | IU/ml | Negative : up to 10 | Negative : up to 10 |
Anti-Histones Ab | IU/ml | Negative : up to 20 | Negative : up to 20 |
Anti-Islet cell Ab (Anti ICA) | Negative: Less than 1/5 | Negative: Less than 1/5 |
|
Anti-MCV | IU/ml | Up to 10 | Up to 10 |
Anti-Neuronal-Ab | Less than 1/20 | Less than 1/20 | |
Anti-Perinuclear factor (APF) | Less than 1/20 | Less than 1/20 | |
Anti-Reticulin Ab | Less than 1/20 | Less than 1/20 | |
Anti-Ribosomal RNA | IU/ml | Negative : up to 20 | Negative : up to 20 |
Anti-Smith (Anti-Sm) | IU/ml | Negative : up to 20 | Negative : up to 20 |
Anti-Striated muscle antibodies | Negative: Less than 1/5 | Negative: Less than 1/5 |
|
Anti-topo-I/Scl-70 | IU/ml | Negative : up to 20 | Negative : up to 20 |
B2-Glycoprotein IgG | U/ml | Negative : < 5 Equivocal : 5 – 8 Positive : > 8 | Negative : < 5 Equivocal : 5 – 8 Positive : > 8 |
B2-Glycoprotein IgM | min | Negative : < 5 Equivocal : 5 – 8 Positive : > 8 | Negative : < 5 Equivocal : 5 – 8 Positive : > 8 |
Casein IgG | U/ml | Up to 1 | Up to 1 |
C-reactive protein (Nephlometric quantitative) | mg/l | Negative : less than 3 | Negative : less than 3 |
Endomysial Ab. (EMA) | Less than 1/5 | Less than 1/5 | |
Gluten IgG | U/ml | Up to 1 | Up to 1 |
LCA-Ab | U/l | Negative : up to 20 | Negative : up to 20 |
Ovary-Ab | U/ml | Up to 10 | Up to 10 |
Rheumatoid factor (Nephlometric quantitative) | IU/ml | Negative : up to 15 | Negative : up to 15 |
Thyroid Anti-Microsomal Ab | IU/ml | Up to 100 | Up to 100 |
Tissue transglutaminase (IgA) | U/ml | Less than 20 | Less than 20 |
Tissue transglutaminase (IgG) | U/ml | Less than 20 | Less than 20 |
Valproic acid (Depakene ) | ?mol/l | Therapeutic level: (50 -100) | Therapeutic level: (50 -100) |
Lithium | mEq/l | Therapeutic level: | Therapeutic level: |
Methotrexate | µmol/L | Risk of toxicity is above 5 after 24 hr. of the dose | Risk of toxicity is above 5 after 24 hr. of the dose |
Sirolimus (Rapamune) | ng/ml | Therapeutic level: (5 – 15) | Therapeutic level: (5 – 15) |
Cyclosporin (Sandimmune) | ng/ml | Therapeutic level: (100 – 400) | Therapeutic level: (100 – 400) |
Tacrolimus | ng/ml | Therapeutic level: (5 – 20) | Therapeutic level: (5 – 20) |
Vancomycin | µg/ml | Trough level: (5 – 10) Peak level: (20 – 40) | Trough level: (5 – 10) Peak level: (20 – 40) |
Theophylline | µg/ml | Therapeutic level: ( 10 – 20 ) | Therapeutic level: ( 10 – 20 ) |
Tricyclic antidepressants (TCA) | Undetectable | Undetectable | |
Phencyclidine (PCP) | Undetectable | Undetectable | |
Activated Protein-C resistance | Negative | Negative | |
Alpha-1-antitrypsin (Serum) | mg/dL | 90 – 200 | 90 – 200 |
Alpha-1-antitrypsin (Stool) | mg/dL | 5.4 – 26.8 | 5.4 – 26.8 |
Anti-Thrombin III | % | 80 – 120 | 80 – 120 |
C1-esterase inhibitor | mg/dL | 18 – 32 | 18 – 32 |
Cold agglutinins | Less than 1/32 | Less than 1/32 | |
Complement 3 (C3) | mg/dL | 90 – 180 | 90 – 180 |
Complement 4 (C4) | mg/dL | 10 – 40 | 10 – 40 |
Complement haemolytic dose – 50 (CH50) | U/ml | 75 – 160 | 75 – 160 |
Erythropoietin (EPO) | mU/ml | 4.3 – 32.9 | 4.3 – 32.9 |
Factor II | % | 70 – 120 | 70 – 120 |
Factor V | % | 70 – 120 | 70 – 120 |
Factor VII | % | 70 – 120 | 70 – 120 |
Factor IX | % | ||
Factor X | % | ||
Factor XI | % | ||
Factor XII | % | ||
Factor XIII | 70 – 120 | 70 – 120 | |
Factor VIII Inhibitor | % | ||
Folic acid (Serum) | ng/ml | 3.1 – 17.5 | 3.1 – 17.5 |
Folic acid (RBCs) | ng/ml | 212 – 584 | 212 – 584 |
Free Protein S | % | 50 -130 | 50 -130 |
Ham’s test | Negative | Negative | |
Haptoglobin | mg/dL | 30 – 200 | 30 – 200 |
Homocysteine | µmol/mL | ||
Immunoglobulin-IgA | |||
Immunoglobulin-IgG | |||
Immunoglobulin-IgG 1 | |||
Immunoglobulin-IgG 2 | |||
Immunoglobulin-IgG 3 | |||
Immunoglobulin-IgG 4 | |||
Immunoglobulin-IgM | |||
Platelet Function | |||
Protein C | |||
Protein S | |||
Phenyl Ketonuria (PKU) | Negative | Negative | |
Sickling test | |||
Soluble transferrin | mg/l | M : 2.2 – 5 | F : 1.9 – 4.4 |
Thrombin time | Sec | Up to 21 | Up to 21 |
Vitamin D | ng/ml | M : 4.92 – 42.7 | F : 6.23 – 49.9 |
Vitamin-B12 | pg/ml | 197 – 866 | 197 – 866 |
Von-Willebrand factor (activity) | % | 50 – 150 | 50 – 150 |
Von-Willebrand factor (concentration) | % | 50 – 150 | 50 – 150 |
Entamoeba histolytica Ab | |||
Entamoeba histolytica Ag | |||
Fasciola Ab (IHA) | |||
Fasciola Ab (ELISA) | |||
Filarial Ab | |||
Giardia Lamblia Ag | |||
Hydatid Ab. (IHA ) | |||
Blood Film | |||
Biological Fluid Examination | |||
Coagulation Profile | |||
Lipid Profile | |||
LDL/Cholesterol | |||
Toxocara canis Ab | |||
Trichinella spiralis Ab | |||
Angiotensin converting Enzyme (ACE) | U/l | 20 – 95 | 20 – 95 |
Aldolase | |||
Cholinesterase | |||
Lactate | |||
Pyruvate | |||
Lactate / Pyruvate Ratio | |||
Myoglobin | |||
Bone Alkaline | ng/ml | M : 6 – 30 | F : premenopausal : |
Osteocalcin | ng/ml | M : 18 – 30 years : 24 – 70 31- 50 years : 14 – 42 51- 70 years : 14 – 46 | F : premenopausal: 11- 43 Post menopausal : 15 – 46 |
Aldosterone | ng/dl | Upright : 3.5 – 30 Supine : 1 – 16 | Upright : 3.5 – 30 Supine : 1 – 16 |
Renin activity | ng/dl | Upright : 0.25 – 2.7 Supine : 0.19 – 1.6 | Upright : 0.25 – 2.7 Supine : 0.19 – 1.6 |
Aldosterone / Renin ratio | |||
Catecholamines ( blood ) | pg/ml | Noradrenaline : up to 600 Adrenaline : up to 125 | Noradrenaline : up to 600 Adrenaline : up to 125 |
Catecholamines ( urine) | µg/day | Noradrenaline : up to 90 Adrenaline : up to 20 | Noradrenaline : up to 90 Adrenaline : up to 20 |
eAG (Estimated average glucose) | |||
Anti-diuretic hormone ( ADH) | 1.3 – 4.1 | 1.3 – 4.1 | |
Leptin | ng/ml | M : 2 – 5.6 | F : 3.7 –11.1 |
Fib-4 | |||
IL-6 | pg/ml | Up to 7 | Up to 7 |
Procalcitonin PCT-Q | |||
Apolipoprotein A 1 | mg/dL | M: 115 – 190 | F: 115 – 220 |
Apolipoprotein B | mg/dL | M: 60 – 138 | F: 52 – 129 |
Lipoprotein (a) | mg/dL | Less than 30 | Less than 30 |
Bile acids | mmol/l | Up to 8 | Up to 8 |
Citrate in urine | mg/day | M: 115 – 922 | F: 250 – 1153 |
GFR by Cystatin C | |||
Dysmorphic RBCs | Negative | Negative | |
eGFR | |||
Urea clearance | 40 – 65 | 40 – 65 | |
Bicarbonate | mmol/l | 22 – 29 | 22 – 29 |
Copper | M: 70 – 140 | F: 76 – 152 | |
Pancreatic elastase | |||
Pro-BNP | pg/ml | Up to 125 | Up to 125 |
pH | 7.35 – 7.45 | 7.35 – 7.45 | |
Reducing substances | Negative | Negative | |
Acrosin activity | AAI | More than 15 | More than 15 |
Alpha – glucosidase | mU/ml | ||
Hypo-osmotic swelling test (hos test) | % | More than 58 | More than 58 |
Mar test (Direct ) | % | Negative : Less than 10 Equivocal : 10 – 40 Positive : More than 40 | Negative : Less than 10 Equivocal : 10 – 40 Positive : More than 40 |
Mar test (Indirect ) | % | Negative | Negative |
Peroxidase test (leuco screen) | cell/ml | Less than 1X10^6 | Less than 1X10^6 |
Vital stain (Eosin-nigrosin test) | % | More than 58 | More than 58 |
DNA Fragmentation Index (DFI) | % | Less than 30 | Less than 30 |
Stone Analysis | |||
F.PSA/T.PSA ratio | More than 0.25 | More than 0.25 | |
Cortisol | µg/ml | AM: 5 – 25 | AM: 5 – 25 |